Evidence map›Paper›PMID 23559007›Full record

ArticleCell death & disease2013

Trolox contributes to Nrf2-mediated protection of human and murine primary alveolar type II cells from injury by cigarette smoke.

E M Messier, K Bahmed, R M Tuder, H W Chu, R P Bowler, B Kosmider

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. 4-Hydroxynonenal, a Potential Biomarker for Lung Inflammatory Diseases.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Protocol for differentiating primary human small airway epithelial cells at the air-liquid interface.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Implications of DNA damage in chronic lung disease.Frontiers in cell and developmental biology · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

E M MessierDepartment of Medicine, National Jewish Health, Denver, CO 80206, USA.
K Bahmed
R M Tuder
H W Chu
R P Bowler
B Kosmider
University of Colorado Denver · USNational Jewish Health · US

Funding

Common targeting of the prostacyclin-PPARy axis in COPD and lung cancerR01CA164780 · NCI · UNIVERSITY OF COLORADO DENVER · PI TUDER, RUBIN M. · 2011 to 2014
$2.3M
RTP-801 in Cigarette Smoke-EmphysemaR01ES016285 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI TUDER, RUBIN M. · 2011 to 2015
$1.6M
NCI NIH HHS R01 CA164780NIEHS NIH HHS R01 ES016285
6 · The paper itself

Abstract

Cigarette smoke (CS) is a main risk factor for chronic obstructive pulmonary disease (COPD). Oxidative stress induced by CS causes DNA and lung damage. Oxidant/antioxidant imbalance occurs in the distal air spaces of smokers and in patients with COPD. We studied the effect of oxidative stress generated by CS both in vivo and in vitro on murine primary alveolar type II (ATII) cells isolated from nuclear erythroid 2-related factor-2 (Nrf2)(-/-) mice. We determined human primary ATII cell injury by CS in vitro and analyzed ATII cells isolated from smoker and non-smoker lung donors ex vivo. We also studied whether trolox (water-soluble derivative of vitamin E) could protect murine and human ATII cells against CS-induced DNA damage and/or decrease injury. We analyzed oxidative stress by 4-hydroxynonenal expression, reactive oxygen species (ROS) generation by Amplex Red Hydrogen Peroxide Assay, Nrf2, heme oxygenase 1, p53 and P53-binding protein 1 (53BP1) expression by immonoblotting, Nrf2 nuclear translocation, Nrf2 and p53 DNA-binding activities, apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay and cytokine production by ELISA. We found that ATII cells isolated from Nrf2(-/-) mice are more susceptible to CS-induced oxidative DNA damage mediated by p53/53BP1 both in vivo and in vitro compared with wild-type mice. Therefore, Nrf2 activation is a key factor to protect ATII cells against injury by CS. Moreover, trolox abolished human ATII cell injury and decreased DNA damage induced by CS in vitro. Furthermore, we found higher inflammation and p53 mRNA expression by RT-PCR in ATII cells isolated from smoker lung donors in comparison with non-smokers ex vivo. Our results indicate that the Nrf2 and p53 cross talk in ATII cells affect the susceptibility of these cells to injury by CS. Trolox can protect against oxidative stress, genotoxicity and inflammation induced by CS through ROS scavenging mechanism, and serve as a potential antioxidant prevention strategy against oxidative injury of ATII cells in CS-related lung diseases.

Indexed as

AldehydesAlveolar Epithelial CellsAnimalsAntioxidantsChromansGene Expression RegulationHeme Oxygenase-1HumansIntracellular Signaling Peptides and ProteinsMiceMice, KnockoutNF-E2-Related Factor 2NicotianaOxidative StressPulmonary AlveoliReactive Oxygen Species4-hydroxy-2-nonenal6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acidAldehydesAntioxidantsChromansHeme Oxygenase-1Intracellular Signaling Peptides and ProteinsNfe2l2 protein, mouseNF-E2-Related Factor 2Reactive Oxygen SpeciesSmokeTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1Tumor Suppressor Protein p53

Identifiers

PMID23559007
PMCPMC3668634
OpenAlexW2007714594

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.